Skip to main content

Advertisement

Table 1 Characteristic of the selected studies on the prevalence of Mets

From: Global prevalence of cardiometabolic risk factors in the military population: a systematic review and meta-analysis

Author, yearCountryStudy typeStudy yearStudy populationSamplingSample sizeMean age/ RangeOutcomeDefinition/CriteriaPrevalence%(95% CI)
Payab, 2017 [13],IranC/S2015MilitaryConvenience220037.73MetsATPIII11.1
(9.8–12.5)
ATPIII with waist> 90 cm26.6
(24.7–28.5)
ATPIII> 95 cm19.6
(17.9–21.3)
Sharma, 2016 [18],IndiaC/SNot providedMilitary
aircrew
Convenience21020–50MetsMS-433.0
(26.6–39.7)
ATPIII11.9
(7.6–16.7)
IDF7.1
(4.0–11.7)
WHO3.8
(1.8–7.6)
Gasier, 2016 [20],USCNot providedNavy
(Submariners)
Convenience5329MetsATP-III30.0
(18.7–44.5)
Baygi, 2016 [21],IranC/S2015SeafarersConvenience23436MetsIDF14.9
(10.8–20.3)
Rhee, 2015 [23],KoreaC/S2014Military aviatorsConvenience91124–49MetsWHO9.8
(7.9–11.9)
Herzog, 2015 [27],USC/S2012MilitaryConvenience79,13918–65MetsATPIII16.7
(15.7–16.2)
Filho, 2014 [9],BrazilC/S2012MilitaryConvenience45245.8MetsATPIII38.5
(34.0–43.2)
Scovill, 2012 [31],USC/SNot providedMarinerConvenience38844MetsATPIII39.0
(34.1–43.9)
Hagnas, 2012 [33],FinlandProspectivNot providedMilitaryConvenience104619.2MetsIDF6.1
(4.8–7.8)
Costa, 2011 [36],BrazilC/S2008NavyConvenience138330.7MetsIDF17.6
(15.6–19.7)
Khazale, 2007 [43],JordanC2006Air forceConvenience11132.5MetsATPIII18
(11.6–26.7)
Al-Qahtani, 2005 [47],Saudi ArabiaC/S2004SoldiersConvenience107920–60MetsATPIII20.8
(18.4–23.3)
Athyros, 2005 [48],GreeceC/S2003MilitaryConvenience30037.0MetsATPIII9.4
(6.4–13.3)
Bauduceau, 2005 [49],FranceC/S2003MilitaryConvenience204538.6MetsATPIII
WHO
9.0
(7.8–10.3)
14.0
(12.5–15.6)
  1. C/S: Cross-sectional; C: Cohort; Mets: Metabolic Syndrome; ATPIII: Adult Treatment Panel III; IDF: International Diabetes Federation; WHO: World Health Organization